Catalyst Wire Dossier Catalyst Wire Dossier

OT-730 Eye Drops

OT-730 · Othera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OT-730 Eye Drops, covering 2009-01-07 to 2009-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [Phase 1, Phase 2]

See pricing